Potential Life-Saving Impact of New Weight-Loss Drugs Highlighted in Study

*Expanding access to highly effective weight-loss drugs could prevent over 40,000 deaths annually in the U.S.* A Yale and University of Florida study underscores the need to remove cost and insurance barriers for treatments like GLP-1 receptor agonists. These medications could significantly reduce obesity-related mortality, particularly in states with high obesity rates.